Skippet raises $2.2m seed to make language the next human-computer interface

Skippet just announced the closing of its $2.2m seed round led by VC fund Neo with participation from Wedbush Ventures, Studio Management, Gaingels, Assure, and prominent US and European angel investors.

Skippet empowers everyone to create custom digital solutions to solve problems without needing to code.

Write out your problem in plain English, and Skippet uses its knowledge of your existing systems and integrations, along with state-of-the-art language models to create or modify an application or workflow.

This is made possible by Skippet’s proprietary architecture which translates natural language into fit-for-purpose solutions.

Solving a problem or implementing a solution should be as easy as describing it.” Jacob, Co-Founder & CEO at Skippet.

Skippet’s founders believe that, from individuals to large organisations, people should be able to seamlessly customise software in a world where business needs are always changing.

Skippet aims to make inflexible and expensive software redundant. 

Launched by the MyMedBot founders team

The team was inspired to build Skippet by their experience in helping over 200 organizations (schools & businesses) through the COVID-19 pandemic.

The company developed MyMedBot, a no-code platform for digitizing COVID-19 communication protocols that automated over 11 million forms.

The founders learned from their customers how many people are excluded from modern technology and are stuck with complicated and inflexible tools offered by expensive software vendors.

Growing the product development team

Headquartered in Luxembourg, the company is fully remote and international, hiring for software development roles across Luxembourg, Europe and the US.

The seed round funding will be used to grow the product development team and roll-out Skippet to the company’s 200 MyMedBot customers and beyond. Skippet will be released in private beta in February 2022.